Evidence map›Paper›PMID 22170288›Full record

ReviewHuman genetics2012

Translational genetic approaches to substance use disorders: bridging the gap between mice and humans.

Abraham A Palmer, Harriet de Wit

Abstract readReview
In one paragraph

Review in Human genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. The genetics of addiction.Human genetics · 2012
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Abraham A PalmerDepartment of Human Genetics, The University of Chicago, Chicago, IL 60637, USA. aap@uchicago.edu
Harriet de Wit
University of Chicago · US

Funding

Determinants of Drug Preference in Humans--Administrative SupplementR01DA002812 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1985 to 2024
$10.6M
Systems Genetic Analysis of Methamphetamine's Motivational Effects in a Mouse AILR01DA021336 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2006 to 2015
$4.0M
REINSTATEMENT OF DRUG TAKINGR01DA009133 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1996 to 2009
$2.5M
The genetic basis of impulsive behavior in humansR01DA032015 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 2011 to 2015
$2.4M
Genome-wide association studies in outbred miceR01GM097737 · NIGMS · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2011 to 2014
$1.9M
FINDING GENES THAT CAUSE QLT FOR FEAR LEARNING AND ANXIETYR01MH079103 · NIMH · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2007 to 2011
$1.9M
Weighted genome-wide association study of amphetamine sensitivity in humansR03DA027545 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2009 to 2010
$466k
Is Ecstasy an Empathogen? Effects of MDMA on Social and Emotional ProcessingR21DA026570 · NIDA · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 2009 to 2010
$424k
Novel Methods to Map Stimulant QTLs in Advanced Intercross LinesR21DA024845 · NIDA · UNIVERSITY OF CHICAGO · PI PALMER, ABRAHAM A · 2008 to 2009
$422k
NIDA NIH HHS R01 DA002812NIDA NIH HHS R01 DA009133NIDA NIH HHS R01DA009133NIDA NIH HHS R01 DA021336NIDA NIH HHS R01DA021336NIDA NIH HHS R01DA02812NIDA NIH HHS R01 DA032015NIDA NIH HHS R01DA032015NIDA NIH HHS R03 DA027545NIDA NIH HHS R03DA027545NIDA NIH HHS R21 DA024845NIDA NIH HHS R21 DA026570NIDA NIH HHS R21DA026570NIGMS NIH HHS R01 GM097737NIGMS NIH HHS R01GM097737NIMH NIH HHS R01 MH079103NIMH NIH HHS R01MH079103
6 · The paper itself

Abstract

While substance abuse disorders only occur in humans, mice and other model organisms can make valuable contributions to genetic studies of these disorders. In this review, we consider a few specific examples of how model organisms have been used in conjunction with studies in humans to study the role of genetic factors in substance use disorders. In some examples genes that were first discovered in mice were subsequently studied in humans. In other examples genes or specific polymorphisms in genes were first studied in humans and then modeled in mice. Using anatomically and temporally specific genetic, pharmacological and other environmental manipulations in conjunction with histological analyses, mechanistic insights that would be difficult to obtain in humans have been obtained in mice. We hope these examples illustrate how novel biological insights about the effect of genes on substance use disorders can be obtained when mouse and human genetic studies are successfully integrated.

Indexed as

Disease Models, AnimalGenetic VariationPhenotypeAnaplastic Lymphoma KinaseAnimalsCarrier ProteinsCasein Kinase 1 epsilonCatechol O-MethyltransferaseGenetic Association StudiesHumansMembrane ProteinsMiceReceptor Protein-Tyrosine KinasesReceptors, NicotinicReceptors, Opioid, muSpecies SpecificityAnaplastic Lymphoma KinaseCarrier ProteinsCasein Kinase 1 epsilonCatechol O-MethyltransferaseMembrane ProteinsMpdz protein, mouseOPRM1 protein, humanReceptor Protein-Tyrosine KinasesReceptors, NicotinicReceptors, Opioid, mu

Identifiers

PMID22170288
PMCPMC3352994
OpenAlexW2006797449

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.